BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20506776)

  • 1. [Is the Gail model for breast cancer risk assessment valid for the Bulgarian women?].
    Baitchev G; Christova P; Ivanov I
    Khirurgiia (Sofiia); 2009; (6):27-30. PubMed ID: 20506776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor.
    Ulusoy C; Kepenekci I; Kose K; Aydintug S; Cam R
    Breast Cancer Res Treat; 2010 Apr; 120(2):419-24. PubMed ID: 19760030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model.
    Novotny J; Pecen L; Petruzelka L; Svobodnik A; Dusek L; Danes J; Skovajsova M
    Breast Cancer Res Treat; 2006 Jan; 95(1):29-35. PubMed ID: 16319995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gail model risk factors: impact of adding an extended family history for breast cancer.
    Crispo A; D'Aiuto G; De Marco M; Rinaldo M; Grimaldi M; Capasso I; Amore A; Bosetti C; La Vecchia C; Montella M
    Breast J; 2008; 14(3):221-7. PubMed ID: 18373641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.
    McTiernan A; Kuniyuki A; Yasui Y; Bowen D; Burke W; Culver JB; Anderson R; Durfy S
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):333-8. PubMed ID: 11319173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do traditional Gail model risk factors account for increased breast cancer in women with lupus?
    Bernatsky S; Ramsey-Goldman R; Boivin JF; Joseph L; Moore AD; Rajan R; Clarke A
    J Rheumatol; 2003 Jul; 30(7):1505-7. PubMed ID: 12858448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk assessment in indigent women at a public hospital.
    Abu-Rustum NR; Herbolsheimer H
    Gynecol Oncol; 2001 May; 81(2):287-90. PubMed ID: 11330964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women.
    Bener A; Çatan F; El Ayoubi HR; Acar A; Ibrahim WH
    J Prim Care Community Health; 2017 Jul; 8(3):180-187. PubMed ID: 28606030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk assessment in women aged 70 and older.
    Vacek PM; Skelly JM; Geller BM
    Breast Cancer Res Treat; 2011 Nov; 130(1):291-9. PubMed ID: 21604157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of developing breast cancer by utilizing Gail model.
    Seyednoori T; Pakseresht S; Roushan Z
    Women Health; 2012; 52(4):391-402. PubMed ID: 22591234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the accuracy of the Gail model in women with atypical hyperplasia.
    Pankratz VS; Hartmann LC; Degnim AC; Vierkant RA; Ghosh K; Vachon CM; Frost MH; Maloney SD; Reynolds C; Boughey JC
    J Clin Oncol; 2008 Nov; 26(33):5374-9. PubMed ID: 18854574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.
    MacKarem G; Roche CA; Hughes KS
    Breast J; 2001; 7(1):34-9. PubMed ID: 11348413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gail model predicts breast cancer in women with suspicious radiographic lesions.
    Weik JL; Lum SS; Esquivel PA; Tully RJ; Bae WC; Petersen FF; Jaque JM; Reeves ME; Garberoglio CA
    Am J Surg; 2005 Oct; 190(4):526-9. PubMed ID: 16164914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypia in the assessment of breast cancer risk: implications for management.
    Vogel VG
    Diagn Cytopathol; 2004 Mar; 30(3):151-7. PubMed ID: 14986294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience.
    Shah C; Berry S; Dekhne N; Lanni T; Lowry H; Vicini F
    Clin Breast Cancer; 2012 Jun; 12(3):215-8. PubMed ID: 22503234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
    Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
    BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.